Diagnostic performance of artificial intelligence algorithms for detection of pulmonary involvement by COVID-19 based on portable radiography.
Ricardo Luis Cobeñas, María de Vedia, Juan Florez, Daniela Jaramillo, Luciana Ferrari, Ricardo Re
Author Information
Ricardo Luis Cobeñas: Departamento de Diagnóstico por Imágenes, Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno (CEMIC), Buenos Aires, Argentina.
María de Vedia: Departamento de Diagnóstico por Imágenes, Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno (CEMIC), Buenos Aires, Argentina.
Juan Florez: Departamento de Diagnóstico por Imágenes, Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno (CEMIC), Buenos Aires, Argentina.
Daniela Jaramillo: Departamento de Diagnóstico por Imágenes, Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno (CEMIC), Buenos Aires, Argentina.
Luciana Ferrari: Departamento de Diagnóstico por Imágenes, Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno (CEMIC), Buenos Aires, Argentina.
Ricardo Re: Departamento de Diagnóstico por Imágenes, Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno (CEMIC), Buenos Aires, Argentina.
Introduction and objectives: To evaluate the diagnostic performance of different artificial intelligence (AI) algorithms for the identification of pulmonary involvement by SARS-CoV-2 based on portable chest radiography (RX). Material and methods: Prospective observational study that included patients admitted for suspected COVID-19 infection in a university hospital between July and November 2020. The reference standard of pulmonary involvement by SARS-CoV-2 comprised a positive PCR test and low-tract respiratory symptoms. Results: 493 patients were included, 140 (28%) with positive PCR and 32 (7%) with SARS-CoV-2 pneumonia. The AI-B algorithm had the best diagnostic performance (areas under the ROC curve AI-B 0.73, vs. AI-A 0.51, vs. AI-C 0.57). Using a detection threshold greater than 55%, AI-B had greater diagnostic performance than the specialist [(area under the curve of 0.68 (95% CI 0.64-0.72), vs. 0.54 (95% CI 0.49-0.59)]. Conclusion: AI algorithms based on portable RX enabled a diagnostic performance comparable to human assessment for the detection of SARS-CoV-2 lung involvement.